If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Olaf Stuve is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Relapsing-Remitting Multiple Sclerosis Medicine & Life Sciences
Neuromyelitis Optica Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Chronic Progressive Multiple Sclerosis Medicine & Life Sciences
Central Nervous System Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Clinical trials in multiple sclerosis: potential future trial designs

Manouchehri, N., Zhang, Y., Salter, A., Hussain, R. Z., Hartung, H. P., Hemmer, B., Linker, R., Segal, B. M., Cutter, G. & Stuve, O., May 1 2019, In : Therapeutic Advances in Neurological Disorders. 12

Research output: Contribution to journalReview article

Open Access
Multiple Sclerosis
Clinical Trials
Biomarkers
Endophenotypes
Therapeutics

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

Stuve, O., Soelberg Soerensen, P., Leist, T., Giovannoni, G., Hyvert, Y., Damian, D., Dangond, F. & Boschert, U., Jun 1 2019, In : Therapeutic Advances in Neurological Disorders. 12

Research output: Contribution to journalArticle

Open Access
Cladribine
Lymphocyte Subsets
Tablets
Multiple Sclerosis
Lymphocytes

Evolution of clinical trials in multiple sclerosis

Zhang, Y., Salter, A., Wallström, E., Cutter, G. & Stuve, O., Feb 1 2019, In : Therapeutic Advances in Neurological Disorders. 12

Research output: Contribution to journalReview article

Multiple Sclerosis
Clinical Trials
Therapeutics
Placebos
Sample Size
2 Citations (Scopus)

Immunological aspects of approved MS therapeutics

Rommer, P. S., Milo, R., Han, M. H., Satyanarayan, S., Sellner, J., Hauer, L., Illes, Z., Warnke, C., Laurent, S., Weber, M. S., Zhang, Y. & Stuve, O., Jan 1 2019, In : Frontiers in immunology. 10, JULY, 1564.

Research output: Contribution to journalReview article

Open Access
ocrelizumab
Multiple Sclerosis
Pharmaceutical Preparations
Cladribine
Chronic Progressive Multiple Sclerosis
1 Citation (Scopus)

MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis

Kuhbandner, K., Hammer, A., Haase, S., Terbrack, E., Hoffmann, A., Schippers, A., Wagner, N., Hussain, R. Z., Miller-Little, W. A., Koh, A., Stoolman, J. S., Segal, B. M., Linker, R. A. & Stuve, O., Jan 1 2019, In : Frontiers in immunology. 10, 1 p.

Research output: Contribution to journalArticle

Open Access
Autoimmune Experimental Encephalomyelitis
Cell Adhesion Molecules
Intestines
Lymphocytes
Multiple Sclerosis